dms retatrutide With approaching ~30% weight loss at 2 years—but with what appears to be a meaningfully higher adverse event burden than earlier-generation incretin therapies—expert clinical guidance… Retatrutide microdosing: guide to split

Culturally, GLP-1s are accelerating a reframing of weight as a biological and systemic issue rather than a moral one

36 Because appetite reduction is common with GLP-1 agonists, and many individuals on GLP-1 therapies are counseled to prioritize protein and/or follow a ketogenic diet to support muscle maintenance during weight loss, fiber intake is often reduced significantly as fruits, vegetables and grains are eliminated

Hold the vial upright on your work surface and pierce the rubber stopper at a 45-degree angle, directing the needle tip toward the vial wall rather than straight down onto the lyophilised powder

TRIUMPH-2 (NCT05929079) will assess bodyweight change in people with overweight/obesity and T2D and include a subset of participants with OSA, in which AHI will also be investigated as a primary endpoint

At its highest dose, patients lost an average of 12.4% of their body weight over 72 weeks

The Bottom Line: The GLP-1 revolution in pediatric weight management is here to stay